134 related articles for article (PubMed ID: 35117360)
1. A comprehensive assessment of the prognostic role of cell adhesion molecules in acute myeloid leukemia.
Cheng J; Han J; Lin C
Transl Cancer Res; 2020 Dec; 9(12):7605-7618. PubMed ID: 35117360
[TBL] [Abstract][Full Text] [Related]
2. Adaptive immunity-related gene expression profile is correlated with clinical phenotype in patients with acute myeloid leukemia.
Chen P; Liu Y; Zhang R; Wang H; Zhang J; Guo M; Du Z
Ann Transl Med; 2021 Jun; 9(11):939. PubMed ID: 34350254
[TBL] [Abstract][Full Text] [Related]
3. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
Lai Y; Sheng L; Wang J; Zhou M; OuYang G
Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
Zhu R; Tao H; Lin W; Tang L; Hu Y
Front Oncol; 2020; 10():574939. PubMed ID: 33330048
[TBL] [Abstract][Full Text] [Related]
5. [A long-term follow-up study of 82 children with acute myeloid leukemia].
Ruan M; Qi BQ; Liu F; Liu TF; Liu XM; Chen XJ; Yang WY; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):730-734. PubMed ID: 30293275
[No Abstract] [Full Text] [Related]
6. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
[TBL] [Abstract][Full Text] [Related]
7. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
8. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
[TBL] [Abstract][Full Text] [Related]
10. DesA Prognostic Risk Model of LncRNAs in Patients With Acute Myeloid Leukaemia Based on TCGA Data.
Ding W; Ling Y; Shi Y; Zheng Z
Front Bioeng Biotechnol; 2022; 10():818905. PubMed ID: 35265597
[No Abstract] [Full Text] [Related]
11. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
Lauber C; Correia N; Trumpp A; Rieger MA; Dolnik A; Bullinger L; Roeder I; Seifert M
Sci Rep; 2020 Jul; 10(1):12761. PubMed ID: 32728112
[TBL] [Abstract][Full Text] [Related]
12. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and prognostic factors in children with non-core binding factor acute myeloid leukemia].
Chen XY; Liu C; Wu WQ; Zhang AL; Liu LP; Lan Y; Cai YL; Ruan M; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2020 May; 22(5):466-472. PubMed ID: 32434642
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of cell adhesion molecules is associated with progression and poor outcomes in endometrial cancer: Analysis of The Cancer Genome Atlas data.
He X; Lei S; Zhang Q; Ma L; Li N; Wang J
Oncol Lett; 2020 Mar; 19(3):1906-1914. PubMed ID: 32194686
[TBL] [Abstract][Full Text] [Related]
15. FIBP is a prognostic biomarker and correlated with clinicalpathological characteristics and immune infiltrates in acute myeloid leukemia.
Ma M; Xu L; Cui W; Huang Y; Chi G
Discov Oncol; 2023 Jun; 14(1):97. PubMed ID: 37310595
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
17. Potentiality of Protein phosphatase Mg
Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
[TBL] [Abstract][Full Text] [Related]
18. High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia.
Li J; Ge Z
BMC Cancer; 2021 Apr; 21(1):475. PubMed ID: 33926391
[TBL] [Abstract][Full Text] [Related]
19. A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia.
Yu Y; Wang H; Yang JJ; Fang S; Wen YN; Jiao YF; Qian K; Le N; Shan RQ; Gao WJ; Hua BL; Li F
Front Oncol; 2023; 13():1144403. PubMed ID: 37064135
[TBL] [Abstract][Full Text] [Related]
20. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
